Blueprint Medicines (BPMC) Prices 4.71M Share Common Offering at $69/Sh

Pre-Open Stock Movers 01/22: (AKCA) (ACMR) (SPCE) Higher; (FCEL) (NVAX) (BPMC) Lower (more...)

Today's Per-Open Stock Movers:

FuelCell Energy (NASDAQ: FCEL) 26% LOWER; reported Q4 EPS of ($0.23), $0.12 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $11 million versus the consensus estimate of $11.51 million.

Novavax (NASDAQ: NVAX) 15.2% LOWER; files prospectus supplement relates to the issuance and sale of up to $100,000,000 of our common stock from time to time through or to our sales agent, B. Riley FBR, Inc., or BRFBR

Akcea Therapeutics, Inc. (NASDAQ:... More

After-Hours Stock Movers 01/21: (NAVI) (CIT) (IBM) Higher; (NVAX) (BPMC) (ADAP) Lower (more...)

Today's After-Hours Stock Movers:

Novavax (NASDAQ: NVAX) 15.2% LOWER; files prospectus supplement relates to the issuance and sale of up to $100,000,000 of our common stock from time to time through or to our sales agent, B. Riley FBR, Inc., or BRFBR

Navient (NASDAQ: NAVI) 6.2% HIGHER; reported Q4 EPS of $0.67, $0.10 better than the analyst estimate of $0.57.

CIT Group Inc. (NYSE: CIT) 5.8% HIGHER; will replace Tanger Factory Outlet... More

Blueprint Medicines (BPMC) Announces Proposed $325M Public Offering of Shares of Common Stoc

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it has commenced an underwritten public offering of $325,000,000 in shares of its common stock. In addition, Blueprint Medicines expects to grant the underwriters a 30-day option to purchase up to an additional $48,750,000 in shares of its common stock in connection with the public offering. All shares of common stock will be offered by Blueprint... More